Previous studies indicated that ERβ is a target for CRC prevention due to its activation reduced intestinal tumor formation and represses oncogenes, while its knockout mice exhibited changes in colonic epithelia [10]. This evidence concerns the gene ESR2 and colorectal carcinoma.